12th Edition

BRAIN METASTASES RESEARCH
AND EMERGING THERAPY CONFERENCE


9th TO 11th OCTOBER
2024 • PARIS

EORTIC logo
PSCC logo


Welcome to the 12th edition of Brain Mets meeting!

Dear Friends,
We are delighted to welcome you to Paris for the twelfth Annual Brain Metastases Research and Emerging Therapy Conference.
Past successful editions have conforted us to organize again the conference. The meeting will be held, as for previous editions under the auspices of EANS and EORTC but, also in association with the Institut Gustave Roussy since our rewarding partnership initiated during the last eleven editions.

This initiative is devoted to accelerate therapeutic discoveries and, to improve care of patients with metastatic CNS malignancies. We anticipate that this cross-sectional meeting will provide a deeper dive into basic and translational research and, also stimulate innovative and insightful clinical trial on brain metastatic patients.
These pre, intra and post diagnosis issues of great unmet need will be addressed in a dynamic and interactive framework.
Several topics will be specifically discussed like challenges in precision medicine management and, the actual role of liquid biopsies for CNS metastases patients. The increasing place of new local treatments and, combined strategies in the era of targeted therapies and immune check point inhibitors will also be addressed.

We are convinced that this conference would constitute an unparalleled platform to share basic, translational, and clinical data and explore new treatment paradigms in this patient population.
Finally, the scientific committee hopes that this meeting will provide a fantastic opportunity to develop networking with all professionals involved in brain metastases management and, lay the foundation for future collaborative projects.

The program chairs
Manmeet Ahluwalia (US), Fabrice Barlési (FR), Frédéric Dhermain (FR), Emilie Le Rhun (CH), Philippe Métellus (FR), Ricardo Soffietti (IT), Michael Weller (CH), Manfred Westphal (DE)